However no correlation was found between AurkA overexpression and clinical and pathological features as grading (Pvalue = 0.759), Ki67 (Pvalue = 0.574), tumor size (Pvalue = 0.553) or linfonodal status (Pvalue = 0.107) in N = 89 breast cancer samples (Table 1). Here, MKI67 is linked to breast carcinoma.